THE J HEALTHCARE INITIATIVE
3-MMC/ 3-Methylmethcathinone
Found in:
Opioids, BZD
Type/Reason added:
DBZD/ Enhance inhibitory effects of opioids
Relative Potency:
N/A
Routes of Administration and Effects
Administration: Common routes include oral ingestion (PO), nasal insufflation (snorting), intravenous (IV) injection, rectal (PR) administration, inhalation, and smoking.
Dosage and Effects:
Oral Dose Range:
-
Light: 25-75 mg
-
Common: 75-150 mg
-
Strong: 150-300 mg+
-
Total Duration (oral): 4-6 hours
-
Onset: 10-30 minutes
-
Peak: 2-3 hours
Nasal Insufflation Duration: 2.5-4.5 hours
-
Onset: 5-10 minutes
-
Peak: 1-1.5 hours
Effects:
-
Produces stimulant effects, such as increased energy, euphoria, and heightened alertness.
-
Short-lived effects compared to some other stimulants.
Information Regarding the Substance
Physical Description: Odorless white to grey powder/solid or crystalline solid.
Side Effects:
-
Common adverse effects include rapid heart rate, restlessness, aggression, high blood pressure, hallucinations, and elevated creatine phosphokinase levels, which can indicate muscle breakdown (rhabdomyolysis) and kidney damage.
-
Reported symptoms of acute intoxication include rapid heart rate, restlessness, high blood pressure, hallucinations, and aggression.
Speak with the professionals
You are not alone, we are here to help.
Feel free to connect with nearby professionals to help what you need.
Don’t worry. We’re here to help.
686868
Chat to support